These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
596 related articles for article (PubMed ID: 28844756)
1. Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. Tapeinos C; Battaglini M; Ciofani G J Control Release; 2017 Oct; 264():306-332. PubMed ID: 28844756 [TBL] [Abstract][Full Text] [Related]
2. Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood-Brain Barrier Transmitters. Amiri M; Jafari S; Kurd M; Mohamadpour H; Khayati M; Ghobadinezhad F; Tavallaei O; Derakhshankhah H; Sadegh Malvajerd S; Izadi Z ACS Chem Neurosci; 2021 Dec; 12(24):4475-4490. PubMed ID: 34841846 [TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462 [TBL] [Abstract][Full Text] [Related]
4. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme. Jnaidi R; Almeida AJ; Gonçalves LM Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927610 [TBL] [Abstract][Full Text] [Related]
5. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related]
6. Lipid-based nanoformulations in the treatment of neurological disorders. Pottoo FH; Sharma S; Javed MN; Barkat MA; Harshita ; Alam MS; Naim MJ; Alam O; Ansari MA; Barreto GE; Ashraf GM Drug Metab Rev; 2020 Feb; 52(1):185-204. PubMed ID: 32116044 [TBL] [Abstract][Full Text] [Related]
7. Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug Delivery and the Effects of Preparation Parameters of Solvent Injection Method. Duong VA; Nguyen TT; Maeng HJ Molecules; 2020 Oct; 25(20):. PubMed ID: 33081021 [TBL] [Abstract][Full Text] [Related]
8. Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors. Mehrdadi S Adv Pharm Bull; 2023 Jul; 13(3):512-520. PubMed ID: 37646057 [TBL] [Abstract][Full Text] [Related]
9. Lipid Nanoparticles for Nasal/Intranasal Drug Delivery. Cunha S; Amaral MH; Lobo JMS; Silva AC Crit Rev Ther Drug Carrier Syst; 2017; 34(3):257-282. PubMed ID: 28845761 [TBL] [Abstract][Full Text] [Related]
10. Lipid Nanoparticles: A Novel Approach for Brain Targeting. Shankar R; Joshi M; Pathak K Pharm Nanotechnol; 2018; 6(2):81-93. PubMed ID: 29886842 [TBL] [Abstract][Full Text] [Related]
11. Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders. Agosti E; Zeppieri M; Antonietti S; Battaglia L; Ius T; Gagliano C; Fontanella MM; Panciani PP Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543223 [TBL] [Abstract][Full Text] [Related]
12. Methods for preparation of nanostructured lipid carriers. Gomaa E; Fathi HA; Eissa NG; Elsabahy M Methods; 2022 Mar; 199():3-8. PubMed ID: 33992771 [TBL] [Abstract][Full Text] [Related]
13. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related]
14. Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation. Sadegh Malvajerd S; Azadi A; Izadi Z; Kurd M; Dara T; Dibaei M; Sharif Zadeh M; Akbari Javar H; Hamidi M ACS Chem Neurosci; 2019 Jan; 10(1):728-739. PubMed ID: 30335941 [TBL] [Abstract][Full Text] [Related]
15. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles. Das S; Ng WK; Tan RB Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790 [TBL] [Abstract][Full Text] [Related]
16. Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment. Zhao C; Zhu X; Tan J; Mei C; Cai X; Kong F Biomed Pharmacother; 2024 Feb; 171():116113. PubMed ID: 38181717 [TBL] [Abstract][Full Text] [Related]
17. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. Teixeira MI; Lopes CM; Amaral MH; Costa PC Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574 [TBL] [Abstract][Full Text] [Related]
18. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics. Pathak K; Keshri L; Shah M Crit Rev Ther Drug Carrier Syst; 2011; 28(4):357-93. PubMed ID: 21967401 [TBL] [Abstract][Full Text] [Related]
19. Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities. Gupta T; Sahoo RK; Singh H; Katke S; Chaurasiya A; Gupta U AAPS PharmSciTech; 2023 Apr; 24(4):102. PubMed ID: 37041350 [TBL] [Abstract][Full Text] [Related]
20. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]